https://www.selleckchem.com/pr....oducts/Temsirolimus.
Tumor-to-aortic enhancement fraction (TAF) was expressed as the ratio of the difference between attenuation of the tumor on arterial and parenchymal images to that between attenuation of the aorta on arterial and pancreatic images. The Kruskal-Wallis analysis of variance and Mann-Whitney test for statistical analysis were used. Forty-two PDAs (23 men and 19 women) were divided into three groups Well-differentiated ( 13), moderately differentiated ( 21), and poorly differentiated ( 8). TAF differed significantly between the three gr